Rodrigo Ruiz Soto
Directeur Technique/Scientifique/R&D chez DECIPHERA PHARMACEUTICALS, INC.
Profil
Rodrigo Ruiz Soto is currently a Senior Director-Medical at ImmunoGen, Inc. and a Senior Vice President-Clinical Development at Deciphera Pharmaceuticals, Inc. He previously worked as a Medical Director at Sanofi, Inc. He holds a doctorate degree from Universidad Nacional Autónoma de México.
Postes actifs de Rodrigo Ruiz Soto
| Sociétés | Poste | Début |
|---|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2017 |
| IMMUNOGEN, INC. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Rodrigo Ruiz Soto
| Sociétés | Poste | Fin |
|---|---|---|
Sanofi, Inc.
 Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Directeur Technique/Scientifique/R&D | - |
Formation de Rodrigo Ruiz Soto
| Universidad Nacional Autónoma de México | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Sanofi, Inc.
Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Retail Trade |
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
